SCHEMBL24026762

SCHEMBL24026762

c1ccc(-n2c3ccccc3c3c4c5ccccc5n5c6cc7c(cc6c(cc32)c45)c2cccc3c4c5c(ccc4n7c23)c2ccccc2n5-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24026760 0.99 KDM4E (0.39) KDM4EATML3MBTL1
SCHEMBL24026765 0.96 KDM4E (0.40) KDM4EATML3MBTL1
SCHEMBL24026764 0.94 KDM4E (0.41) KDM4EATML3MBTL1
SCHEMBL24026834 0.92 KDM4E (0.41) KDM4EATML3MBTL1
SCHEMBL21126731 0.92 KDM4E (0.41) KDM4EATML3MBTL1
SCHEMBL24026744 0.91 KDM4E (0.42) KDM4EATML3MBTL1
SCHEMBL24026573 0.91 KDM4E (0.44) KDM4EATML3MBTL1
SCHEMBL24026574 0.91 KDM4E (0.46) KDM4EATML3MBTL1
SCHEMBL24026824 0.91 KDM4E (0.46) KDM4EATML3MBTL1
SCHEMBL24026743 0.90 KDM4E (0.41) KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359221-A1 COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359221-A1 COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME HAX1, AFF4, XPO4 KDM4E 1097/4885ATM 3938/4885L3MBTL1 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.